Related references
Note: Only part of the references are listed.Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: A Mendelian randomization study
Nikos Papadimitriou et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
S. Loi et al.
ANNALS OF ONCOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer
Olivia A. Maguire et al.
CELL METABOLISM (2021)
Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
Danian Dai et al.
FRONTIERS IN ONCOLOGY (2021)
STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth
Chunyan Zhang et al.
CELL METABOLISM (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
C. Criscitiello et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Alison E. Ringel et al.
CELL (2020)
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
Christine Lundgren et al.
BREAST CANCER RESEARCH (2020)
Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
Ozgecan Dulgar et al.
EUROPEAN JOURNAL OF BREAST HEALTH (2020)
Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial
Signe Korsgaard Skriver et al.
BREAST CANCER RESEARCH (2020)
Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
Michail Ignatiadis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
Michail Ignatiadis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Bile acid metabolites control TH17 and Treg cell differentiation
Saiyu Hang et al.
NATURE (2019)
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Li Zhu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells
Trang H. Luu et al.
CELLULAR ONCOLOGY (2018)
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness
Edit Miko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer
G. Pruneri et al.
ANNALS OF ONCOLOGY (2016)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide
Kannan Krishnamurthy et al.
BREAST CANCER RESEARCH (2008)
Share Paper
